LEXARIA BIOSCIENCE CORP (LEXX)
US52886N4060 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 260K -63.89% | 230K -11.54% | 464.28K 101.86% | 558.96K 20.39% | 1.192M 113.25% | 3.588M 201.01% | 50.14M 1,297.44% | 137.9M 175.03% | 224.11M 62.52% | 325.74M 45.35% | 395.29M 21.35% | |
| EBITDA YoY % growth | -7.28M -34.57% | -6.38M 12.36% | -5.677M 11.02% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -7.38M -33.70% | -6.53M 11.52% | -5.753M 11.90% | -7.745M -34.62% | -9.014M -16.39% | -17.75M -96.91% | 23.913M 234.72% | 98.289M 311.03% | 167.17M 70.08% | 247.4M 47.99% | 300.22M 21.35% | |
| Operating Margin | -2,838.46% | -2,839.13% | -1,239.15% | -1,385.58% | -756.23% | -494.71% | 47.69% | 71.28% | 74.59% | 75.95% | 75.95% | |
| EPS YoY % growth | N/A 2.06% | N/A -15.79% | -0.46 59.00% | -0.45 3.17% | -0.48 -7.63% | -0.88 -82.98% | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.08 -36.00% | -0.08 37.23% | -0.08 41.71% |
| Revenue Q2Q % growth | 204K 40.69% | 204K 142.86% | 204K 142.86% |
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.16 -23.08% | -0.08 | -0.08 | -96.08% |
| Q4 2024 Q2Q % growth | -0.14 -16.67% | -0.11 | -0.03 | -24.78% |
| Q3 2024 Q2Q % growth | -0.13 64.86% | -0.11 | -0.02 | -23.34% |
| Q2 2024 Q2Q % growth | -0.06 | -0.10 | 0.04 | 41.18% |
| Q1 2024 Q2Q % growth | -0.13 56.67% | -0.11 | -0.02 | -15.86% |
| Q4 2023 Q2Q % growth | -0.12 50.00% | -0.14 | 0.02 | 12.85% |
| Q3 2023 Q2Q % growth | -0.37 9.76% | -0.26 | -0.11 | -45.10% |
| Q4 2022 Q2Q % growth | -0.24 -10.09% | -0.21 | -0.03 | -12.04% |
| Q3 2022 Q2Q % growth | -0.41 -2.50% | -0.29 | -0.12 | -43.56% |
| Q2 2022 Q2Q % growth | -0.25 | 0.21 | -0.46 | -216.71% |
| Q4 2021 Q2Q % growth | -0.22 | -0.23 | 0.02 | 7.08% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 180K 18.98% | 204K | -24K | -11.76% |
| Q4 2024 Q2Q % growth | 84K | 178.5K | -94.5K | -52.94% |
| Q3 2024 Q2Q % growth | 84K -9.82% | 153K | -69K | -45.10% |
| Q2 2024 Q2Q % growth | 145K 262.50% | % | ||
| Q1 2024 Q2Q % growth | 151.28K 51.28% | % | ||
| Q4 2023 Q2Q % growth | -100.00% | 178.5K | -178.5K | -100.00% |
| Q3 2023 Q2Q % growth | 93.15K -6.85% | 81.6K | 11.55K | 14.15% |
| Q2 2023 Q2Q % growth | 40K 33.33% | % | ||
| Q1 2023 Q2Q % growth | 100K 900.00% | % | ||
| Q4 2022 Q2Q % growth | 110K 266.67% | 198.9K | -88.9K | -44.70% |
| Q3 2022 Q2Q % growth | 100K -50.00% | 122.4K | -22.4K | -18.30% |
| Q2 2022 Q2Q % growth | 30K -84.21% | 153K | -123K | -80.39% |
| Q1 2022 Q2Q % growth | 10K -96.67% | % | ||
| Q4 2021 Q2Q % growth | 30K -50.00% | 255K | -225K | -88.24% |
| Q3 2021 Q2Q % growth | 200K 400.00% | % | ||
| Q2 2021 Q2Q % growth | 190K -5.00% | % | ||
| Q1 2021 Q2Q % growth | 300K 2,900.00% | % | ||
| Q4 2020 Q2Q % growth | 60K -53.85% | % | ||
| Q3 2020 Q2Q % growth | 40K -33.33% | % | ||
| Q2 2020 Q2Q % growth | 200K 900.00% | % | ||
| Q1 2020 Q2Q % growth | 10K -50.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | N/A | -11.97% | -11.97% |
| Revenue | 0% | N/A | -30.41% | -30.41% |